EX-2.5
from SC 13D
13 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.4
from SC 13D
14 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.3
from SC 13D
13 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.2
from SC 13D
19 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.5
from DEFA14A
15 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.5
from 8-K
15 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.4
from DEFA14A
15 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.4
from 8-K
15 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.3
from 8-K
15 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.3
from DEFA14A
15 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.2
from DEFA14A
23 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.2
from 8-K
23 pages
Voting Agreement Dated as of April 24, 2017 (This “Agreement”), Among Fresenius Kabi AG, a German Stock Corporation (“Parent”), and Each of the Individuals and Other Parties Listed on Schedule a Attached Hereto (Each, a “Shareholder” And, Collectively, the “Shareholders”)
12/34/56
EX-2.1
from 8-K
111 pages
Agreement and Plan of Merger by and Among Akorn, Inc. (A Louisiana Corporation), Akorn Enterprises II, Inc. (A Delaware Corporation and Wholly-Owned Subsidiary of Purchaser) Vpi Holdings Corp. (A Delaware Corporation) and Tailwind Management LP, as Equityholder Representative Dated as of May 9, 2014
12/34/56
EX-2.1
from 8-K
77 pages
Portions of This Exhibit Indicated by “[***]” Have Been Omitted, and Such Omitted Portions Have Been Filed Separately With the Securities and Exchange Commission. Confidential Treatment Has Been Requested With Respect to the Omitted Portions. Stock and Asset Purchase and License Agreement Among Merck & Co., Inc., Merck Sharp & Dohme Corp., Inspire Pharmaceuticals, Inc., and Oak Pharmaceuticals, Inc. November 15, 2013
12/34/56
